During the past decade, CLINRESCO, ARWYP Medical Suites conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CLINRESCO, ARWYP Medical Suites" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Colitis, Ulcerative" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "CLINRESCO, ARWYP Medical Suites" in a lesser frequency.

Most popular intervention types in "CLINRESCO, ARWYP Medical Suites" are "Drug" (5 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ontamalimab" (4 trials), "Placebo" (4 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "Vedolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "CLINRESCO, ARWYP Medical Suites" are 6 trials for "All" genders.

Currently, there are NaN active trials in "CLINRESCO, ARWYP Medical Suites". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CLINRESCO, ARWYP Medical Suites, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CLINRESCO, ARWYP Medical Suites, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".